netFormulary
 Report : A-Z HCD items in Formulary 15/01/2021 18:25:08
[Back]
 
Section Status HCD Name
11.08.02 Restricted Use Cancer Drugs Fund Aflibercept Eylea®
05.03.03.02 Restricted Use Cancer Drugs Fund Boceprevir Victrellis®
03.04.03 Restricted Use Cancer Drugs Fund C1 Esterase Inhibitor Berinert®
05.03.03.02 Restricted Use Cancer Drugs Fund Daclatasvir Daklinza®
05.03.03.02 Restricted Use Cancer Drugs Fund Dasabuvir Exviera®
08.01.05 Restricted Use Cancer Drugs Fund Dasatinib Sprycel®
05.03.03.02 Restricted Use Cancer Drugs Fund Elbasvir-grazoprevir Zepatier®
05.03.03.01 Restricted Use Cancer Drugs Fund Entecavir Baraclude®
14.05.01 Restricted Use Cancer Drugs Fund Normal Immunoglobulin Iqymune®, Privigen®, Gammaplex®, Intratect®. and others
05.03.03.02 Restricted Use Cancer Drugs Fund Ombistavir/paritaprevir/ritonavir  Viekirax®
08.02.04 Formulary Cancer Drugs Fund Panobinostat Farydak®
08.01.05 Restricted Use Cancer Drugs Fund Pertuzumab  Perjeta®
09.01.07 Restricted Use Cancer Drugs Fund Plerixafor Mozobil®
11.08.02 Restricted Use Cancer Drugs Fund Ranibizumab Lucentis®
05.03.03.02 Restricted Use Cancer Drugs Fund Simeprevir Olysio®
05.03.03.02 Restricted Use Cancer Drugs Fund Sofosbuvir Sovaldi®
05.03.03.02 Restricted Use Cancer Drugs Fund Sofosbuvir/ledipasvir Harvoni®
05.03.03.02 Restricted Use Cancer Drugs Fund Telaprevir  Incivo®
Joint Medicines Formulary